NAG-thiazoline
NAG-thiazoline is a O-GlcNAcase inhibitor with a Ki of 180 nM. NAG-thiazoline is a potent GH20 GlcNAcase (VhGlcNAcase) inhibitor with an IC50 of 11.9 μM and a Ki of 62 µM[1].
Product Specifications
CAS Number
179030-22-9
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bacterial; OGA
Type
Reference compound
Related Pathways
Anti-infection; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/nag-thiazoline.html
Purity
98.08
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O[C@@H]1[C@]2([H])[C@](SC(C)=N2)([H])O[C@@H]([C@H]1O)CO
Molecular Formula
C8H13NO4S
Molecular Weight
219.26
Precautions
H302, H315, H319, H335
References & Citations
[1]Macauley MS, et al. Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase. Biochim Biophys Acta. 2010 Feb;1800 (2) :107-21. |[2]Piyanat Meekrathok, et al. NAG-thiazoline is a potent inhibitor of the Vibrio campbellii GH20 β-N-Acetylglucosaminidase. FEBS J. 2020 Nov;287 (22) :4982-4995.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2-(1-Ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one](https://cdn.genprice.uk/products/572/4807471847696/imageurl/trc-e184180-250mg.webp)
TRC-E184180-250MG 250 mg
2-(1-Ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one
Sign In for Pricing
View Details 
LC422106 20 µg
Angiopoietin like 4 (ANGPTL4) (NM_001039667) Human Over-expression Lysate
Sign In for Pricing
View Details 
